Results 91 to 100 of about 2,077 (188)

Microablative fractional CO2 laser improves dyspareunia related to vulvovaginal atrophy: A pilot study

open access: yes, 2014
methods: The intensity of VVA symptoms was recorded for each patient. Patients were administered the Short Form 12 (SF-12) and the female sexual function index (FSFI) to assess quality of life and sexual function, respectively. An objective evaluation of
Salvatore, Stefano   +21 more
core   +1 more source

A randomized controlled trial to evaluate the efficacy of low dose vaginal estrogens in the treatment of vulvovaginal atrophy

open access: yes, 2013
Objective: This study was designed to evaluate the use of low dose vaginal estriol and low dose vaginal estradiol creams for the treatment of vulvovaginal atrophy. Methods: We designed a 12-week randomized double blinded pilot study. Participants applied
Mac Bride, Maire Brid
core  

Features of the vaginal microbiome in postmenopausal vulvovaginal atrophy

open access: yesМедицинский вестник Юга России
Objective: to study the features of the vaginal microbiome in women with postmenopausal OVA and to conduct a comparative analysis of the microbiota in groups with varying degrees of severity of symptoms.Materials and methods: a prospective study was ...
M. I. Biryukova   +2 more
doaj   +1 more source

A comparison of hyaluronic acid and estradiol treatment in vulvovaginal atrophy.

open access: yesEuropean review for medical and pharmacological sciences
This study aims to compare the effects of vaginal estrogen and hyaluronic acid on vulvovaginal atrophy.This randomized controlled study included a total of 300 patients, with 150 patients in each group (Group E and Group H). The VHI score was determined based on a pre-treatment evaluation conducted by a gynecologist.
Jafarzade, A.   +5 more
openaire   +2 more sources

Fractional microablative CO2 laser in breast cancer survivors affected by iatrogenic vulvovaginal atrophy after failure of nonestrogenic local treatments: a retrospective study

open access: yes, 2017
Vulvovaginal atrophy (VVA) is a condition frequently observed in menopause. Its symptoms can significantly affect the quality of life of patients. Since VVA is related to estrogen deficiency, chemotherapy and hormone therapy for breast cancer (BC) might ...
Schettini, Francesco   +27 more
core   +1 more source

New Innovations for the Treatment of Vulvovaginal Atrophy: An Up-to-Date Review. [PDF]

open access: yesMedicina (Kaunas), 2022
Benini V   +9 more
europepmc   +1 more source

Management of osteoporosis and menopausal symptoms: focus on bazedoxifene/conjugated estrogen combination

open access: yesInternational Journal of Women's Health, 2013
Sebastian Mirkin,1 James H Pickar21Pfizer Inc, Collegeville, PA, 2Department of Obstetrics and Gynecology, Columbia University Medical Center, New York, NY, USAAbstract: Loss of estrogen production in women during menopause results in a state of estrogen
Mirkin S, Pickar JH
doaj  

Comparison of topical estrogen and platelet-rich plasma injections in the treatment of postmenopausal vaginal atrophy

open access: yesFrontiers in Medicine
BackgroundPlatelet-rich plasma (PRP) is considered safe and is a low-cost, simple, natural, and minimally invasive method for vaginal rejuvenation. We aimed to compare the effects of hormonal treatment options and PRP use for postmenopausal vulvovaginal ...
Ufuk Atlihan   +5 more
doaj   +1 more source

Home - About - Disclaimer - Privacy